Rhythm Pharmaceuticals, Inc. (RYTM)
87.69
-2.82
(-3.12%)
USD |
NASDAQ |
Mar 17, 16:00
87.69
0.00 (0.00%)
After-Hours: 16:34
Rhythm Pharmaceuticals Total Assets (Quarterly) : 481.19M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| MannKind Corp. | 792.18M |
| Ligand Pharmaceuticals, Inc. | 1.561B |
| Sarepta Therapeutics, Inc. | 3.350B |
| GeoVax Labs, Inc. | 6.731M |
| Ultragenyx Pharmaceutical, Inc. | 1.532B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 342.12M |
| Shareholders Equity (Quarterly) | 139.07M |
| Debt to Equity Ratio | 1.748 |
| Current Ratio | 4.407 |
| Net Debt Paydown Yield | 0.03% |